Status: Recruiting
Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy
Evaluation of efficacy and safety of pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulva cancer.
Participants needed: 42
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: AGO Research GmbHUpdated: May 11, 2026Locations: 15
Eligibility criteria
Signed written informed consent obtained prior to initiation of any study-specif... [+9]
Non squamous cell histology [+42]